Reprieve Cardiovascular Raises $61M in Series B

Reprieve Cardiovascular has successfully raised $61M in a Series B at a $300M valuation led by New Enterprise Associates, Sofinnova Partners.

Company Overview

Reprieve Cardiovascular is a HealthTech company headquartered in Milford, MA, founded in 2018 with 70+ employees.

Developer of therapy for acute decompensated heart failure

Fundraising Details

Amount Raised: $61M
Round Type: Series B
Valuation: $300M
Date: 2025-09-29
Investors: New Enterprise Associates, Sofinnova Partners

About Reprieve Cardiovascular

Developer of therapy for acute decompensated heart failure The company is positioned in the HealthTech sector, serving a growing market with innovative solutions.

Key Information

Headquarters: Milford, MA
Founded: 2018
Team Size: 70+
Industry: HealthTech

What This Means

This funding round demonstrates strong investor confidence in Reprieve Cardiovascular's vision and execution. The capital will likely be used to:

Scale Operations: Expand the team and operational capacity
Product Development: Enhance existing products and develop new features
Market Expansion: Enter new markets and strengthen presence in existing ones
Technology Investment: Invest in infrastructure and technology capabilities

Industry Context

The HealthTech sector continues to attract significant investment as companies innovate to meet evolving market demands. Reprieve Cardiovascular's successful fundraising reflects the strong fundamentals and growth potential in this space.

Valuation Milestone

Reaching a $300M valuation marks an important milestone for Reprieve Cardiovascular, positioning the company among notable players in the HealthTech industry.

Looking Ahead

With this new capital, Reprieve Cardiovascular is well-positioned to execute on its growth strategy and continue building innovative solutions in the HealthTech space. The company's trajectory will be one to watch as it deploys this funding to achieve its next phase of growth.

This fundraising news was reported on 2025-09-29. For more information about Reprieve Cardiovascular, visit their headquarters at Milford, MA.